Weekly Rounds: Vaporized Hydrogen Peroxide, Gonorrhea Treatment, Chikungunya, and More

Here are 5 highlights from Infection Control Today^®'s (ICT^®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.

FDA Recognizes Vaporized Hydrogen Peroxide (VHP) as Established Sterilization Method for Medical Devices
FDA designates vaporized hydrogen peroxide (VHP) as an Established Category A sterilization method, reducing reliance on Ethylene Oxide. Boosting innovation for safer, effective medical device sterilization.

Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327
With gonorrhea's rising antibiotic resistance, Recce 327 by Recce Pharmaceuticals emerges as a game-changer, showing 99% efficacy in preclinical trials and promising potential against antibiotic-resistant bacteria globally.

A Breakthrough Approach to Chikungunya Prevention: Understanding T Cell Vaccines
In this final of 3 segments of an interview with ICT, Thomas Rademacher, Emergex co-founder, delves into T cell-based vaccines for chikungunya, likening immune programming to software, emphasizing the urgency of prevention in endemic regions.

SHEA/IDSA/APIC Answer to Diekema, et al, Study on Prevention of MRSA Infection and Transmission

Society for Healthcare Epidemiology of America/Infectious Diseases Society of America/Association for Professionals in Infection Control and Epidemiology answer Diekema, et al, about MRSA prevention strategies.

Florida Surgeon General Raises Concerns Over DNA Contaminants in Pfizer and Moderna COVID-19 Vaccines

Joseph A. Ladapo, MD, PhD-ASTHO, calls for the halt of these vaccines; however, the FDA disagrees and says that “misinformation and disinformation about these vaccines…results in vaccine hesitancy.”